Literature DB >> 23002374

Clopidogrel versus Other Antiplatelet Agents for Secondary Prevention of Vascular Events in Adults with Acute Coronary Syndrome or Peripheral Vascular Disease: Clinical and Cost-Effectiveness Analyses.

S Banerjee, A Brown, L McGahan, K Asakawa, B Hutton, M Clark, M Severn, M Sharma, Jl Cox.   

Abstract

Entities:  

Year:  2012        PMID： 23002374      PMCID： PMC3442610     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  19 in total

Review 1.  Publication and related biases.

Authors:  F Song; A J Eastwood; S Gilbody; L Duley; A J Sutton
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

2.  Measuring diagnoses: ICD code accuracy.

Authors:  Kimberly J O'Malley; Karon F Cook; Matt D Price; Kimberly Raiford Wildes; John F Hurdle; Carol M Ashton
Journal:  Health Serv Res       Date:  2005-10       Impact factor: 3.402

3.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann
Journal:  Eur Heart J       Date:  2006-08       Impact factor: 29.983

4.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.

Authors:  S Yusuf; F Zhao; S R Mehta; S Chrolavicius; G Tognoni; K K Fox
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

6.  Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial.

Authors:  Paul Kolm; Yong Yuan; Emir Veledar; Shamir R Mehta; Judith A O'Brien; William S Weintraub
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

7.  Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Robert A Harrington; Richard C Becker; Christopher P Cannon; David Gutterman; A Michael Lincoff; Jeffrey J Popma; Gabriel Steg; Gordon H Guyatt; Shaun G Goodman
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Richard C Becker; Thomas W Meade; Peter B Berger; Michael Ezekowitz; Christopher M O'Connor; David A Vorchheimer; Gordon H Guyatt; Daniel B Mark; Robert A Harrington
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Michael Sobel; Raymond Verhaeghe
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 10.  Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

Authors:  C Main; S Palmer; S Griffin; L Jones; V Orton; M Sculpher; R Henderson; C Sudlow; N Hawkins; R Riemsma
Journal:  Health Technol Assess       Date:  2004-10       Impact factor: 4.014
View more
  2 in total

1.  Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome.

Authors:  Y Wang; B P Yan; D Liew; V W Y Lee
Journal:  Pharmacogenomics J       Date:  2017-01-24       Impact factor: 3.550

2.  Do ethical considerations influence any in HTA reports? A review of reports.

Authors:  Alireza Shams Moattar; Fariba Asghari; Reza Majdzadeh
Journal:  Med J Islam Repub Iran       Date:  2016-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.